Douglas Hanahan
Researcher Next ID · RN-029824
Researcher · Medicine
Brussels, United States
- Works count
- 398
- Citation count
- 190,306
- H-index
- 122
- i10-index
- 230
Research interests
Publications
Embracing cancer complexity: Hallmarks of systemic disease
Cell · 2024 · https://doi.org/10.1016/j.cell.2024.02.009
Synaptic proximity enables NMDAR signalling to promote brain metastasis
Nature · 2019 · https://doi.org/10.1038/s41586-019-1576-6
The consensus molecular subtypes of colorectal cancer
Nature Medicine · 2015 · https://doi.org/10.1038/nm.3967
A colorectal cancer classification system that associates cellular phenotype and responses to therapy
Nature Medicine · 2013 · https://doi.org/10.1038/nm.3175
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Cancer Cell · 2012 · https://doi.org/10.1016/j.ccr.2012.02.022
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Nature Medicine · 2011 · 10.1038/nm.2344
Hallmarks of Cancer: The Next Generation
Cell · 2011 · https://doi.org/10.1016/j.cell.2011.02.013
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner
Cancer Cell · 2010 · 10.1016/j.ccr.2009.12.041
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Cancer Cell · 2009 · 10.1016/j.ccr.2009.10.013
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Cancer Cell · 2009 · 10.1016/j.ccr.2009.01.027
Modes of resistance to anti-angiogenic therapy
Nature reviews. Cancer · 2008 · 10.1038/nrc2442
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
Cancer Cell · 2005 · 10.1016/j.ccr.2005.09.005
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
Journal of Clinical Investigation · 2003 · 10.1172/jci17929
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
Journal of Clinical Investigation · 2003 · 10.1172/jci200317929
MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Cell · 2000 · 10.1016/s0092-8674(00)00139-2
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Nature Cell Biology · 2000 · 10.1038/35036374
The Hallmarks of Cancer
Cell · 2000 · https://doi.org/10.1016/s0092-8674(00)81683-9
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Genes & Development · 1999 · 10.1101/gad.13.11.1382
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Science · 1999 · 10.1126/science.284.5415.808
MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes
Cell · 1998 · 10.1016/s0092-8674(00)81169-1
Signaling Vascular Morphogenesis and Maintenance
Science · 1997 · 10.1126/science.277.5322.48
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
Cell · 1996 · https://doi.org/10.1016/s0092-8674(00)80108-7
Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants.
Proceedings of the National Academy of Sciences · 1990 · 10.1073/pnas.87.12.4645
Induction of angiogenesis during the transition from hyperplasia to neoplasia
Nature · 1989 · 10.1038/339058a0
Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes
Nature · 1985 · 10.1038/315115a0
Studies on transformation of Escherichia coli with plasmids
Journal of Molecular Biology · 1983 · https://doi.org/10.1016/s0022-2836(83)80284-8
Plasmid screening at high colony density
Gene · 1980 · 10.1016/0378-1119(80)90144-4
Current projects
No projects listed.